Mesa Laboratories, Inc. (NASDAQ:MLAB) declared a quarterly dividend on Tuesday, January 2nd, Zacks reports. Stockholders of record on Wednesday, February 28th will be paid a dividend of 0.16 per share by the medical instruments supplier on Thursday, March 15th. This represents a $0.64 annualized dividend and a dividend yield of 0.51%. The ex-dividend date of this dividend is Tuesday, February 27th.

Mesa Laboratories has increased its dividend payment by an average of 3.9% per year over the last three years. Mesa Laboratories has a dividend payout ratio of 25.9% indicating that its dividend is sufficiently covered by earnings. Equities research analysts expect Mesa Laboratories to earn $2.46 per share next year, which means the company should continue to be able to cover its $0.64 annual dividend with an expected future payout ratio of 26.0%.

Shares of Mesa Laboratories (NASDAQ:MLAB) traded up $0.47 during trading hours on Wednesday, hitting $124.77. The stock had a trading volume of 21,800 shares, compared to its average volume of 17,450. Mesa Laboratories has a 1 year low of $113.57 and a 1 year high of $169.80. The stock has a market capitalization of $469.82, a PE ratio of 45.04 and a beta of 0.42. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.97 and a current ratio of 2.86.

Mesa Laboratories (NASDAQ:MLAB) last announced its quarterly earnings data on Monday, November 6th. The medical instruments supplier reported $0.60 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.64 by ($0.04). Mesa Laboratories had a return on equity of 14.77% and a net margin of 11.48%. The firm had revenue of $22.95 million during the quarter, compared to analysts’ expectations of $25.50 million. research analysts expect that Mesa Laboratories will post 2.47 EPS for the current fiscal year.

Several analysts recently commented on MLAB shares. Zacks Investment Research raised Mesa Laboratories from a “strong sell” rating to a “buy” rating and set a $167.00 target price on the stock in a report on Tuesday, October 3rd. TheStreet raised Mesa Laboratories from a “c+” rating to a “b” rating in a report on Monday, November 6th.

COPYRIGHT VIOLATION NOTICE: This report was first published by American Banking News and is the property of of American Banking News. If you are accessing this report on another site, it was illegally copied and reposted in violation of United States & international copyright & trademark legislation. The correct version of this report can be read at

About Mesa Laboratories

Mesa Laboratories, Inc is focused primarily on quality control products and services. The Company operates through four segments: Instruments, Continuous Monitoring, Biological Indicators and Cold Chain. The Instruments Division designs, manufactures and markets quality control instruments and disposable products.

Dividend History for Mesa Laboratories (NASDAQ:MLAB)

Receive News & Ratings for Mesa Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesa Laboratories and related companies with's FREE daily email newsletter.